+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Grifols, S.A. - logo

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

From
Neurodegenerative Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Recombinant Proteins Market 2025-2029 - Product Thumbnail Image

Recombinant Proteins Market 2025-2029

  • Report
  • April 2025
  • 203 Pages
  • Global
From
Immunohematology Market 2024-2028 - Product Thumbnail Image

Immunohematology Market 2024-2028

  • Report
  • May 2024
  • 169 Pages
  • Global
From
Autoimmune Disease Diagnostics Market 2024-2028 - Product Thumbnail Image

Autoimmune Disease Diagnostics Market 2024-2028

  • Report
  • November 2023
  • 162 Pages
  • Global
From
Global Blood Testing Market, Forecast to 2029 - Product Thumbnail Image

Global Blood Testing Market, Forecast to 2029

  • Report
  • January 2022
  • 149 Pages
  • Global
From
Plasma Protein Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Plasma Protein Therapeutics Market Report and Forecast 2024-2032

  • Report
  • October 2023
  • 140 Pages
  • Global
From
Fatigue - Pipeline Insight, 2025 - Product Thumbnail Image

Fatigue - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator